Literature DB >> 32377953

Pharmacotherapy of Sexual Addiction.

Leo Malandain1, Jean-Victor Blanc2, Florian Ferreri2, Florence Thibaut3,4.   

Abstract

PURPOSE OF REVIEW: We reviewed recent data on sexual addiction and its treatment. We examined the different definitions of this disorder, related to the pathophysiological mechanisms. We addressed the pharmacological treatment of sexual addiction. RECENT
FINDINGS: Hypersexual behavior can be considered an addictive disorder. Sexual addiction is accompanied by significant psychiatric and addictive comorbidities and is responsible for life impairment. A comprehensive and efficient treatment must be proposed. Selective serotonin reuptake inhibitors seem the first-line pharmacological treatment for sexual addiction. Naltrexone could be another therapeutic option. Psychotherapy and preferentially cognitive-behavioral therapy should be used in association with pharmacotherapy and treatments of comorbidities.

Entities:  

Keywords:  Chemsex; Compulsive sexual behavior; Hypersexuality; Pharmacological treatment; SSRI; Sexual addiction

Year:  2020        PMID: 32377953     DOI: 10.1007/s11920-020-01153-4

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  1 in total

1.  First case report of tDCS efficacy in severe chemsex addiction
.

Authors:  Léo Malandain; Jean-Victor Blanc; Florian Ferreri; Timothée Giorgiadis; Sophie Mosser; Stéphane Mouchabac; Florence Thibaut
Journal:  Dialogues Clin Neurosci       Date:  2020-09       Impact factor: 5.986

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.